IBDEI1U9 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32380,0)
 ;;=E23.0^^182^1984^30
 ;;^UTILITY(U,$J,358.3,32380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32380,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,32380,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,32380,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,32381,0)
 ;;=E27.1^^182^1984^48
 ;;^UTILITY(U,$J,358.3,32381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32381,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,32381,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,32381,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,32382,0)
 ;;=E27.2^^182^1984^1
 ;;^UTILITY(U,$J,358.3,32382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32382,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,32382,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,32382,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,32383,0)
 ;;=E27.3^^182^1984^22
 ;;^UTILITY(U,$J,358.3,32383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32383,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,32383,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,32383,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,32384,0)
 ;;=E29.1^^182^1984^49
 ;;^UTILITY(U,$J,358.3,32384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32384,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,32384,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,32384,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,32385,0)
 ;;=E55.9^^182^1984^56
 ;;^UTILITY(U,$J,358.3,32385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32385,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,32385,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,32385,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,32386,0)
 ;;=E66.01^^182^1984^37
 ;;^UTILITY(U,$J,358.3,32386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32386,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,32386,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,32386,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,32387,0)
 ;;=E66.8^^182^1984^41
 ;;^UTILITY(U,$J,358.3,32387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32387,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,32387,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,32387,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,32388,0)
 ;;=E66.9^^182^1984^42
 ;;^UTILITY(U,$J,358.3,32388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32388,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,32388,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,32388,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,32389,0)
 ;;=E74.39^^182^1984^34
 ;;^UTILITY(U,$J,358.3,32389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32389,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,32389,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,32389,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,32390,0)
 ;;=E83.30^^182^1984^44
 ;;^UTILITY(U,$J,358.3,32390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32390,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,32390,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,32390,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,32391,0)
 ;;=E83.51^^182^1984^27
 ;;^UTILITY(U,$J,358.3,32391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32391,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,32391,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,32391,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,32392,0)
 ;;=E83.52^^182^1984^25
 ;;^UTILITY(U,$J,358.3,32392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32392,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,32392,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,32392,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,32393,0)
 ;;=E87.5^^182^1984^26
 ;;^UTILITY(U,$J,358.3,32393,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1U9
